Us Astrazeneca
-
{
- All
- News
-
US Authorizes AstraZeneca Covid Treatment In Some Cases
US health authorities on Wednesday authorized the use of synthetic antibodies developed by AstraZeneca to prevent Covid-19 infections in people who react badly to vaccines.
-
US Will Consider Sending AstraZeneca Vaccine To Covid-Hit India: Top Expert
The United States will consider sending surplus AstraZeneca vaccines to India, as backlash over its stockpile grows and the South Asian giant reels from a Covid-19 surge, top US pandemic advisor Anthony Fauci said Sunday.
-
AstraZeneca Vaccine Found 79% Effective In US Trials
AstraZeneca's COVID-19 vaccine performed better than expected in a major late-stage trial potentially paving the way for its emergency authorization in the United States and bolstering confidence in the shot after numerous setbacks in Europe.
-
US Expects To Approve UK-Backed AstraZeneca-Oxford Vaccine In April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
-
US Authorizes AstraZeneca Covid Treatment In Some Cases
US health authorities on Wednesday authorized the use of synthetic antibodies developed by AstraZeneca to prevent Covid-19 infections in people who react badly to vaccines.
-
US Will Consider Sending AstraZeneca Vaccine To Covid-Hit India: Top Expert
The United States will consider sending surplus AstraZeneca vaccines to India, as backlash over its stockpile grows and the South Asian giant reels from a Covid-19 surge, top US pandemic advisor Anthony Fauci said Sunday.
-
AstraZeneca Vaccine Found 79% Effective In US Trials
AstraZeneca's COVID-19 vaccine performed better than expected in a major late-stage trial potentially paving the way for its emergency authorization in the United States and bolstering confidence in the shot after numerous setbacks in Europe.
-
US Expects To Approve UK-Backed AstraZeneca-Oxford Vaccine In April
The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.
